Stem cell transplantation for non-Hodgkin's lymphoma.
Non-Hodgkin's lymphoma (NHL) includes a diverse set of conditions ranging from high-grade aggressive to more indolent low-grade disease. Hematopoietic stem cell transplantation (HSCT) has a valuable role in the management of these conditions and can provide long-term remission in selected cases. This article presents the current use of allogeneic and autologous HSCT in a number of subtypes of NHL.
Wrench
David
D
Centre for Medical Oncology, Barts and The London School of Medicine, Charterhouse Square, London EC1M 6BQ, UK.
Gribben
John G
JG
D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000145:classification / Q000628:therapy*; D012074:Remission Induction / Q000379:methods; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous